Literature DB >> 33732721

Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker.

Ralph Wendt1,2, Sven Kalbitz2, Felix Otto3, Tanja Falter4, Joachim Beige1,2,5, Heidi Rossmann4, Bernhard Lämmle6,7,8.   

Abstract

A 43-year-old Armenian patient was diagnosed with salmonella infection and thrombotic microangiopathy (TMA). The clinical course was benign with resolution of all laboratory alterations after antibiotic treatment. Constantly deficient ADAMTS13 activity without ADAMTS13 inhibitors and evidence of homozygosity for a rare complex ADAMTS13 allele led to the diagnosis of congenital thrombotic thrombocytopenic purpura (cTTP). Half-life of ADAMTS13 after plasma infusion was calculated (27,6h) and double blinded plasma infusion as well as ergometric exercise with and without prior plasma infusion undertaken to investigate suspected smoldering TTP activity.
Copyright © 2021 Wendt, Kalbitz, Otto, Falter, Beige, Rossmann and Lämmle.

Entities:  

Keywords:  ADAMTS13; TMA; Upshaw Schulman syndrome; cTTP; hereditary TTP

Year:  2021        PMID: 33732721      PMCID: PMC7959797          DOI: 10.3389/fmed.2021.639441

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  30 in total

1.  A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13.

Authors:  Sara C Meyer; Ramzi Jeddi; Balkis Meddeb; Emna Gouider; Bernhard Lämmle; Johanna A Kremer Hovinga
Journal:  Ann Hematol       Date:  2008-04-29       Impact factor: 3.673

2.  Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.

Authors:  David G Motto; Anil K Chauhan; Guojing Zhu; Jonathon Homeister; Colin B Lamb; Karl C Desch; Weirui Zhang; Han-Mou Tsai; Denisa D Wagner; David Ginsburg
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  A common origin of the 4143insA ADAMTS13 mutation.

Authors:  Reinhard Schneppenheim; Johanna A Kremer Hovinga; Tim Becker; Ulrich Budde; Diana Karpman; Wolfgang Brockhaus; Ingrid Hrachovinová; Bartosz Korczowski; Florian Oyen; Simon Rittich; Johannes von Rosen; Geir E Tjønnfjord; John E Pimanda; Thomas F Wienker; Bernhard Lämmle
Journal:  Thromb Haemost       Date:  2006-07       Impact factor: 5.249

4.  Stealth thrombosis of brain and kidney in a girl with Upshaw-Schulman syndrome not receiving prophylactic plasma infusions.

Authors:  Saori Tanabe; Yoshihiro Fujimura; Bernhard Lämmle; Toshiyuki Kimura; Ayami Isonishi; Kazuya Sakai; Masanori Matsumoto
Journal:  Int J Hematol       Date:  2020-09-23       Impact factor: 2.490

5.  Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

Authors:  Hasan Fattah; Dhiren Kumar; James N George; H Davis Massey; Anne L King; Kenneth D Friedman; Gaurav Gupta
Journal:  Transfusion       Date:  2017-09-20       Impact factor: 3.157

6.  Major blood group antigens--a determinant of factor VIII levels in blood?

Authors:  D Mohanty; K Ghosh; N Marwaha; S Kaur; A P Chauhan; K C Das
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

7.  Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.

Authors:  M Furlan; R Robles; B Morselli; P Sandoz; B Lämmle
Journal:  Thromb Haemost       Date:  1999-01       Impact factor: 5.249

8.  Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

Authors:  Eric Mariotte; Elie Azoulay; Lionel Galicier; Eric Rondeau; Fouzia Zouiti; Pierre Boisseau; Pascale Poullin; Emmanuel de Maistre; François Provôt; Yahsou Delmas; Pierre Perez; Ygal Benhamou; Alain Stepanian; Paul Coppo; Agnès Veyradier
Journal:  Lancet Haematol       Date:  2016-04-16       Impact factor: 18.959

9.  The effect of ABO blood group on the diagnosis of von Willebrand disease.

Authors:  J C Gill; J Endres-Brooks; P J Bauer; W J Marks; R R Montgomery
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

10.  Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.

Authors:  Luca A Lotta; Haifeng M Wu; Ian J Mackie; Marina Noris; Agnes Veyradier; Marie A Scully; Giuseppe Remuzzi; Paul Coppo; Ri Liesner; Roberta Donadelli; Chantal Loirat; Richard A Gibbs; April Horne; Shangbin Yang; Isabella Garagiola; Khaled M Musallam; Flora Peyvandi
Journal:  Blood       Date:  2012-04-23       Impact factor: 22.113

View more
  1 in total

Review 1.  Flavorubredoxin, a Candidate Trigger Related to Thrombotic Thrombocytopenic Purpura: Screening of the Complete Genome of a Salmonella enterica Serovar Typhimurium Isolate From an AIDS Case.

Authors:  Zhouhan Wang; Hao Xu; Beiqing Gu; Yanqi Jin; Tianyuan Wang; Jindi Ma; Yingfeng Lu; Xiaopeng Yu; Beiwen Zheng; Yimin Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-10       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.